Who makes ETD001 single dose?

ETD001 single dose is developed by Enterprise Therapeutics Ltd.

What development phase is ETD001 single dose in?

ETD001 single dose is in Phase 1.

Last reviewed 2026-04-19 · How we verify

ETD001 single dose

Enterprise Therapeutics Ltd · Phase 1 active Small molecule

At a glance

Generic name	ETD001 single dose
Sponsor	Enterprise Therapeutics Ltd
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

ETD001 single dose CI brief — competitive landscape report
ETD001 single dose updates RSS · CI watch RSS
Enterprise Therapeutics Ltd portfolio CI